Computational modeling approaches to studying the dynamics of oncolytic viruses

Related Experiment Video

Updated: May 9, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Dominik Wodarz1

  • 1Department of Ecology and Evolutionary Biology, University of California, 321 Steinhaus Hall, Irvine, CA 92617, USA. dwodarz@uci.edu

Mathematical Biosciences and Engineering : MBE
|August 3, 2013
PubMed

Insights

Mathematical models help analyze oncolytic virus therapy dynamics. This review covers modeling approaches and insights for improving cancer treatments using oncolytic viruses.

Area of Science:

  • Oncology
  • Virology
  • Mathematical Biology
  • Computational Biology

Background:

  • Oncolytic viruses offer targeted cancer therapy by infecting, replicating within, and destroying cancer cells.
  • Despite their potential, consistent clinical success with oncolytic virus therapy remains a challenge.
  • Mathematical modeling is crucial for understanding the complex interactions between oncolytic viruses and tumor dynamics.

Purpose of the Study:

  • To review various mathematical modeling approaches for oncolytic virus-tumor interactions.
  • To discuss model robustness and its implications for therapeutic development.
  • To highlight clinically relevant insights derived from mathematical models.

Main Methods:

  • Review of mathematical modeling techniques, including ordinary differential equations (ODEs) and agent-based models (ABMs).
  • Analysis of model robustness and parameter sensitivity.
  • Synthesis of findings from existing literature on oncolytic virus modeling.

Main Results:

  • Different modeling approaches offer varying levels of detail and predictive power.
  • Model robustness is critical for reliable predictions in oncolytic virotherapy.
  • Modeling provides insights into optimal viral dosing, spread, and tumor cell killing.

Conclusions:

  • Mathematical models are indispensable tools for advancing oncolytic virus therapy.
  • Further development of robust and validated models will accelerate clinical translation.
  • Interdisciplinary collaboration between biologists, clinicians, and modelers is key to success.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Ex Vivo Infection of Live Tissue with Oncolytic Viruses12:08

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Pharmacodynamic Models: Overview01:27

Pharmacodynamic Models: Overview

Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
Viral Replication: Lytic Cycle01:20

Viral Replication: Lytic Cycle

Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Viral Replication: Lysogenic Cycle01:16

Viral Replication: Lysogenic Cycle

The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects its...